CHRISTUS Trinity Mother Frances Hospital - Winnsboro
719 W Coke Rd, Winnsboro, TX · Christushealth · · NPI 1659308948
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.05 – $0.05 | 1 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.10 – $1.88 | 2 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $7.15 – $14.36 | 2 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.65 – $3.02 | 2 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $312.76 – $312.76 | 1 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $323.19 – $323.19 | 1 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $1.21 – $3.42 | 2 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $632.88 – $957.60 | 2 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $4.05 – $4.39 | 2 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $3.32 – $14.93 | 2 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $29.39 – $46.21 | 2 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $3.47 – $18.81 | 2 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $60.00 – $85.16 | 2 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $226.58 – $226.58 | 1 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $7.32 – $8.65 | 2 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $116.47 – $204.02 | 2 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,772.80 – $5,154.78 | 2 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $1.66 – $4.38 | 2 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $1.96 – $2.75 | 2 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $192.00 – $272.51 | 2 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $5.29 – $10.57 | 2 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $70.43 – $185.69 | 2 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $14.45 – $15.85 | 2 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,685,266.67 – $3,685,266.67 | 1 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $0.56 – $2.94 | 2 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $62.92 – $137.19 | 2 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $105.85 – $152.04 | 2 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $73.91 – $176.20 | 2 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.48 – $1.95 | 2 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.18 – $8.34 | 2 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $34.13 – $34.13 | 1 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $76.95 – $95.49 | 2 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $9.67 – $38.73 | 2 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.50 – $3.64 | 2 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $72.32 – $77.30 | 2 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.14 – $0.41 | 2 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $484.40 – $769.11 | 2 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $340.77 – $1,039.42 | 6 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $64.72 – $64.72 | 1 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $1.92 – $2.46 | 2 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $223.65 – $223.65 | 1 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $223.65 – $223.65 | 1 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.67 – $23.05 | 2 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $49.18 – $81.58 | 2 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.92 – $3.33 | 2 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.45 – $3.74 | 2 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.49 – $1.93 | 2 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $84.80 – $126.42 | 2 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $25.42 – $115.90 | 2 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.33 – $2.24 | 2 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.82 – $1.37 | 2 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.03 – $35.82 | 2 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $24.38 – $56.64 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $0.41 | 2 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $6.40 – $15.29 | 2 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $5.14 – $12.91 | 2 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $6.34 – $31.28 | 2 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,286,000.00 – $3,286,000.00 | 1 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $318.85 – $495.63 | 2 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $23.39 – $36.70 | 2 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,146.26 – $3,837.24 | 2 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $3.76 – $5.34 | 2 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $157.10 – $2,361.07 | 2 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $32.15 – $73.26 | 2 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $951.53 – $951.53 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $773.80 – $1,258.29 | 2 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $337.98 – $337.98 | 1 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $2.26 – $3.63 | 2 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.09 – $4.05 | 2 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.11 – $2.82 | 2 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $0.97 – $0.97 | 1 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.31 – $0.46 | 2 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $47.57 – $66.14 | 2 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $243.63 – $333.77 | 2 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $25.22 – $41.01 | 2 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $8.57 – $18.84 | 2 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $7.10 – $18.52 | 2 |
| Inj multihance HCPCS A9577 | not published | not published | $1.82 – $3.69 | 2 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.81 – $3.69 | 2 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.31 – $2.46 | 2 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $28.22 – $28.22 | 1 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $641.83 – $867.24 | 2 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | not published | not published | $712.36 – $712.36 | 1 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.17 – $3.28 | 2 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.58 – $180.59 | 2 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $709.01 – $1,049.54 | 6 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $709.01 – $1,049.54 | 6 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,688.92 – $1,688.92 | 1 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $41.88 – $80.03 | 2 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $46.82 – $155.05 | 2 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $58.94 – $84.66 | 2 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $0.67 – $1.30 | 2 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $381.24 – $720.56 | 2 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $5.34 – $7.49 | 2 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $3.87 – $5.90 | 2 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,423,131.23 – $2,423,131.23 | 1 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $28.74 – $176.20 | 2 |
| Inj, pafolacianine, 0.1 mg HCPCS A9603 | not published | not published | $226.22 – $226.22 | 1 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $1.86 – $59.91 | 2 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | not published | not published | $7.80 – $11.20 | 2 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.